چکیده مقاله
Breast cancer remains a leading cause of cancer related mortality in women globally, with over 2 3 million new cases annually While targeted therapies and precision medicine have advanced treatment, significant challenges persist, particularly for triple negative and chemotherapy resistant subtypes Curcumin from Curcuma longa demonstrates unique multi target anticancer properties, though its clinical application has historically been limited by poor oral bioavailability typically
کلیدواژهها
نویسندگان
Elham Ansarian
Department of Food Science and Technology, Faculty of Agriculture, University of Tabriz, Tabriz, Iran
Mandana Bimakr
Department of Food Science and Engineering, Faculty of Agriculture, University of Zanjan, Zanjan, Iran
Ali Ganjloo
Department of Food Science and Engineering, Faculty of Agriculture, University of Zanjan, Zanjan, Iran
شیوه ارجاع
Ansarian, Elham and Bimakr, Mandana and Ganjloo, Ali,1404,Curcumin as Adjunct Therapy for Breast Cancer: Promise, Challenges, and Future Directions,The Second International Congress of Cancer,Zanjan
ارائهشده در
مجموعه مقالات دومین کنگره بین المللی پیشگیری از سرطان8 مهر 1404 · زنجان